Purified anti-mouse CD8a Antibody

Pricing & Availability
Clone
53-6.7 (See other available formats)
Regulatory Status
RUO
Other Names
T8, Lyt2, Ly-2
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
53-6dot7_Purified_041106
C57BL/6 mouse splenocytes were stained with purified CD8 (clone 53-6.7) (filled histogram) or rat IgG2a, κ isotype control (open histogram), followed by anti-rat IgG FITC.
  • 53-6dot7_Purified_041106
    C57BL/6 mouse splenocytes were stained with purified CD8 (clone 53-6.7) (filled histogram) or rat IgG2a, κ isotype control (open histogram), followed by anti-rat IgG FITC.
  • 53-6dot7_Purified_IHC_011917
    C57BL/6 frozen mouse spleen section was fixed with 4% paraformaldehyde (PFA) for ten minutes at room temperature and blocked with 5% FBS for 30 minutes at room temperature. Then the section was stained with 10 µg/mL of purified anti-mouse CD8a (clone 53-6.7), 10 µg/mL of Alexa Fluor® 647 anti-CD20 (green) overnight at 4°C, followed by 2.5 µg/mL of Alexa Fluor® 594 anti-rat IgG2a (clone MRG2a-83) (red) for two hours at room temperature. The image was captured by 10X objective.
  • 53-6dot7_Purified_IHC_102418
    Fresh, frozen mouse spleen was stained with purified CD8a clone 53-6.7 conjugated and detected with a Cy3 CODEX™ oligonucleotide duplex (red). Samples were counterstained with B220 FITC (green). Data generated at Akoya Biosciences, Inc. using the CODEX™ technology.
Compare all formats
Cat # Size Price Quantity Check Availability Save
100701 50 µg 29€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100702 500 µg 86€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/mL
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
CyTOF®, IHC-F - Verified
IP - Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µL volume. For immunohistochemistry on frozen tissue sections, the suggested use of this reagent is 5.0 - 10 µg per mL. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References

(PubMed link indicates BioLegend citation)
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  30. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Kobayashi A, et al. 2021. Front Immunol. 12:650856. PubMed
  2. Tersteegen A, et al. 2021. Infect Immun. 89:. PubMed
  3. Dallari S, et al. 2017. Nat Commun. 8:14830. PubMed
  4. Toubai T, et al. 2017. Blood Adv. 1.095138889. PubMed
  5. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  6. Bajaña S, et al. 2021. Front Immunol. 11:577718. PubMed
  7. Murata A, et al. 2020. Front Immunol. 11:775. PubMed
  8. Wang C, et al. 2020. Oncoimmunology. 9:1809947. PubMed
  9. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
  10. Kao C, et al. 2005. Int Immunol. 1.824305556. PubMed
  11. Krovi SH, et al. 2019. Proc Natl Acad Sci U S A. 116:22252. PubMed
  12. Thelin MA, et al. 2017. Diabetes. 66:2220. PubMed
  13. Thi VAD, et al. 2019. Mol Cells. 42:869. PubMed
  14. Asthagiri Arunkumar G, et al. 2019. Vaccine. 37:5567. PubMed
  15. Burrello C, et al. 2018. Front Med (Lausanne). 5:21. PubMed
  16. Chartrand K, et al. 2018. Front Immunol. 1.642361111. PubMed
  17. Boldison J, et al. 2020. Cell Mol Immunol. 17:843. PubMed
  18. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  19. Rubio‐Patiño C et al. 2018. Cell metabolism. 27(4):828-842 . PubMed
  20. Rieck M, et al. 2017. Eur J Immunol. 47:677. PubMed
  21. Goel S, et al. 2017. Nature. 548:471. PubMed
  22. Bradford BM, et al. 2018. Parasite Immunol. 40:e12566. PubMed
  23. Field CS, et al. 2018. Oncoimmunology. 7:e1376154. PubMed
  24. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  25. Haque M, et al. 2021. Viruses. 13:. PubMed
  26. Mayer JU, et al. 2020. Front Immunol. 11:592325. PubMed
  27. Tian K, et al. 2021. J Immunol Res. 2021:6297332. PubMed
  28. Nguyen N, et al. 2022. iScience. 25:103679. PubMed
  29. Hirano J, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  30. Draganov D, et al. 2021. NPJ Breast Cancer. 7:22. PubMed
  31. Rossi DC, et al. 2021. J Clin Invest. 131:. PubMed
  32. Carpenter SM, et al. 2017. PLoS Pathog. 13:e1006704. PubMed
  33. Gao J, et al. 2017. Oncol Lett. 14:2954. PubMed
  34. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  35. Willimsky G, et al. 2021. Elife. 10:. PubMed
  36. Tian D, et al. 2020. FASEB J. 34:3367. PubMed
  37. Stefanescu C, et al. 2021. Front Oncol. 11:765151. PubMed
  38. Zhou AC, et al. 2017. Front Immunol. 1.136111111. PubMed
  39. Ma C, et al. 2018. Science. 360:eaan5931. PubMed
  40. Kaplanov I, et al. 2019. Proc Natl Acad Sci U S A. 116:1361. PubMed
  41. Niss Arfelt K, et al. 2017. Blood. 129:866. PubMed
  42. Jackson JW, et al. 2021. Mol Ther Oncolytics. 22:444. PubMed
  43. Mayer KA, et al. 2021. FASEB J. 35:e21217. PubMed
  44. Peng V, et al. 2020. J Biol Chem. 295:14866. PubMed
  45. Yang M, et al. 2020. Oncoimmunology. 9:1708064. PubMed
  46. Hiramatsu-Asano S, et al. 2021. Front Immunol. 11:616141. PubMed
  47. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  48. Bartsch YC, et al. 2018. Front Immunol. 1.196527778. PubMed
  49. Morabito KM, et al. 2017. Mucosal Immunol. 0.795138889. PubMed
  50. Recino A, et al. 2019. Gene Ther. 26:40. PubMed
  51. Wang N, et al. 2021. Mol Ther Oncolytics. 20:71. PubMed
  52. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  53. Yan J, et al. 2020. Cancer Immunol Res. 8:356. PubMed
  54. Chen L, et al. 2020. Front Immunol. 11:584458. PubMed
  55. Doorduijn EM, et al. 2018. Front Immunol. 0.416666667. PubMed
  56. Sun H, et al. 2018. J Cell Biol. 217:1453. PubMed
  57. Chen S, et al. 2018. Immunohorizons. 0.345138889. PubMed
  58. Guo Y, et al. 2008. Blood. 112:480. PubMed
  59. Sharma M, et al. 2020. Nat Commun. 11:661. PubMed
  60. Bertino P, et al. 2019. Oncoimmunology. 8:1601482. PubMed
  61. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  62. Yang SH, et al. 2017. Front Immunol. 8:1192. PubMed
  63. Zhao L, et al. 2018. Nat Med. 24:1536. PubMed
  64. Hiratsuka S, et al. 2018. EMBO Mol Med. 10:e8643. PubMed
  65. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  66. Mori H, et al. 2015. Toxicol Pathol. 43: 883-889. PubMed
  67. Gozgit JM, et al. 2021. Cancer Cell. :. PubMed
  68. Lasso P, et al. 2020. Front Immunol. 584959:11. PubMed
  69. Xie D, et al. 2020. Eur J Immunol. 50:1729. PubMed
  70. Liu H, et al. 2020. J Immunol. 205:1207. PubMed
  71. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  72. Furukawa K,et al. 2017. PLoS One. 10.1371/journal.pone.0184901. PubMed
  73. Zhao F, et al. 2018. Cancer Immunol Res. 1.263194444. PubMed
  74. Gartlan KH, et al. 2019. Blood Adv. 2.110416667. PubMed
  75. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  76. Sharba S, et al. 2019. Virulence. 10:97. PubMed
  77. Zhong X, et al. 2020. Proc Natl Acad Sci U S A. 8563:117. PubMed
  78. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  79. Hsiao CC, et al. 2021. Cells. 10:. PubMed
  80. Dooley K, et al. 2021. Mol Ther. 29:1729. PubMed
  81. Dai Z, et al. 2021. JCI Insight. 6: . PubMed
  82. Kim SJ, et al. 2017. Nat Immunol. 18:1016. PubMed
  83. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  84. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  85. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  86. Jang SC, et al. 2021. Commun Biol. 4:497. PubMed
  87. You X, et al. 2022. Front Genet. 12:790990. PubMed
  88. Sprouse ML, et al. 2018. JCI Insight. 3:e97322. PubMed
  89. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  90. Sheppard S, et al. 2018. Front Immunol. 1.630555556. PubMed
  91. Sharabi A, et al. 2019. JCI Insight. 4:e126294. PubMed
  92. Chihara N, et al. 2018. Nature. 558:454. PubMed
  93. Shin J, et al. 2018. Diabetes. 67:1068. PubMed
  94. Majer O, et al. 2019. Nature. 575:366. PubMed
  95. Zelazowska MA, et al. 2020. Life Sci Alliance. :3. PubMed
  96. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  97. Gilfillan CB, et al. 2020. Eur J Immunol. 50:505. PubMed
  98. Chen HW, et al. 2021. Biomedicines. 9:. PubMed
  99. Kenna T, et al. 2008. Blood. 111:2091. PubMed
  100. King IL, et al. 2017. Mucosal Immunol. 10:1160. PubMed
  101. Yates K, et al. 2018. Proc Natl Acad Sci U S A. 115:2162. PubMed
  102. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  103. Oyarce K, et al. 2018. Front Immunol. 9:112. PubMed
  104. Bajic D, et al. 2020. Mol Cancer Ther. 19:2554. PubMed
  105. Ikezoe T, et al. 2021. Biomolecules. 11:. PubMed
  106. Li J, et al. 2021. Front Immunol. 12:710406. PubMed
  107. Dionisio-Santos DA, et al. 2021. Front Neurosci. 15:758677. PubMed
  108. Tan CL, et al. 2018. Immunohorizons. 0.248611111. PubMed
  109. Mensurado S, et al. 2018. PLoS Biol. 16:e2004990. PubMed
  110. Yoon BH, et al. 2018. Mol Cells. 41:953. PubMed
  111. Goh W, et al. 2020. Cell Rep. 33:108285. PubMed
  112. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  113. Kakaradov B, et al. 2017. Nat Immunol. 18:422. PubMed
  114. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  115. Rosenbaum M, et al. 2019. Nat Commun. 2.05. PubMed
  116. Meyers JL, et al. 2018. PLoS One. 13:e0207007. PubMed
  117. Kawabe T, et al. 2017. Sci Immunol. 2:eaam9315. PubMed
  118. Shissler SC, et al. 2020. Sci Rep. 10:8218. PubMed
  119. Scortegagna M, et al. 2020. Nat Commun. 11:99. PubMed
  120. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  121. Tsai MS, et al. 2021. Int J Mol Sci. 22:. PubMed
  122. Duncan CG, et al. 2018. G3 (Bethesda). 0.892361111. PubMed
  123. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  124. Ko S, et al. 2005. J Immunol. 175:3309. PubMed
  125. Zhang Z, et al. 2020. Front Immunol. 1.844444444. PubMed
  126. Lin Z, et al. 2021. Stem Cells. 39:240. PubMed
  127. Amobi-McCloud A, et al. 2021. Front Immunol. 12:678999. PubMed
  128. Brown ZJ, et al. 2018. Cell Death Dis. 0.805555556. PubMed
  129. Stelekati E, et al. 2018. Cell Rep. 2.445833333. PubMed
  130. Cui X, et al. 2017. J Immunol. 199:4066. PubMed
  131. Sami E, et al. 2020. Cancer Res. 80:1102. PubMed
  132. Dey P, et al. 2020. Cancer Discov. 10:608. PubMed
  133. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  134. Udumula MP, et al. 2021. Mol Metab. 53:101272. PubMed
  135. Zhang C, et al. 2018. Cell Res. 28:323. PubMed
  136. Afzali B, et al. 2017. Nat Immunol. 18:813. PubMed
  137. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  138. Satoh–Takayama N, et al. 2020. Immunity. 52(4):635-649. PubMed
  139. Lee B, et al. 2019. Front Immunol. 0.561805556. PubMed
  140. Freed-Pastor WA, et al. 2021. Cancer Cell. :. PubMed
  141. Fujimura N, et al. 2016. J Vasc Surg. 64: 46-54. PubMed
  142. Kang JG, et al. 2020. PLoS Negl Trop Dis. 14:e0007813. PubMed
  143. Gorgun FM, et al. 2021. Front Oncol. 11:701968. PubMed
  144. Englezou PC, et al. 2018. Mol Ther Nucleic Acids. 12:118. PubMed
  145. Cole C, et al. 2018. Nucleic Acids Res. 46:e62. PubMed
  146. Sutherland APR, et al. 2019. Sci Rep. 9:15302. PubMed
  147. Yamashita M, et al. 2019. Cell Stem Cell. 25:357. PubMed
  148. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  149. Pittala S, et al. 2018. Neoplasia. 9:20222. PubMed
  150. Lin J, et al. 2017. Nat Commun. . 10.1038/s41467-017-01477-5. PubMed
  151. Huppé CA, et al. 2018. Mucosal Immunol. 0.536111111. PubMed
  152. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  153. Cong L, et al. 2021. Breast Cancer Res. 23:51. PubMed
  154. Zhang N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  155. Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed
  156. Song M, et al. 2020. Nat Commun. 11:6298. PubMed
  157. Liu H, et al. 2022. Animal Model Exp Med. 5:72. PubMed
  158. Lee YJ, et al. 2018. FASEB J. 32:4658. PubMed
  159. Atif SM, et al. 2019. JCI Insight. 4:e125494. PubMed
  160. Khameneh HJ, et al. 2017. J Immunol. 198:196. PubMed
  161. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  162. Genton C, et al. 2006. J Immunol. 177:2285. PubMed
  163. Jordan J, et al. 2008. Infect Immun. 76:3717. PubMed
  164. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  165. Prabakaran T, et al. 2021. EBioMedicine. 66:103314. PubMed
  166. Sutiwisesak R, et al. 2020. PLoS Pathog. 16:e1009000. PubMed
  167. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  168. Fritz Y, et al. 2017. J Invest Dermatol. 137:696. PubMed
  169. Chen YQ, et al. 2019. J Immunother Cancer. 0.415277778. PubMed
  170. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
RRID
AB_312740 (BioLegend Cat. No. 100701)
AB_312741 (BioLegend Cat. No. 100702)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8a on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD8a Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD8a 53-6.7 FC
Biotin anti-mouse CD8a 53-6.7 FC, IHC
FITC anti-mouse CD8a 53-6.7 FC
PE anti-mouse CD8a 53-6.7 FC
PE/Cyanine5 anti-mouse CD8a 53-6.7 FC
Purified anti-mouse CD8a 53-6.7 FC, CyTOF®, IHC-F, IP
PE/Cyanine7 anti-mouse CD8a 53-6.7 FC
APC/Cyanine7 anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 488 anti-mouse CD8a 53-6.7 FC, 3D IHC
Alexa Fluor® 647 anti-mouse CD8a 53-6.7 FC, IHC-F, 3D IHC, SB
Pacific Blue™ anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 700 anti-mouse CD8a 53-6.7 FC
PerCP/Cyanine5.5 anti-mouse CD8a 53-6.7 FC
PerCP anti-mouse CD8a 53-6.7 FC
Brilliant Violet 421™ anti-mouse CD8a 53-6.7 FC, IHC, SB
Brilliant Violet 570™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 650™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 605™ anti-mouse CD8a 53-6.7 FC
Ultra-LEAF™ Purified anti-mouse CD8a 53-6.7 FC, CyTOF®, IHC, IP, Depletion, Block
Brilliant Violet 711™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 785™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 510™ anti-mouse CD8a 53-6.7 FC
Purified anti-mouse CD8a (Maxpar® Ready) 53-6.7 FC, CyTOF®
Alexa Fluor® 594 anti-mouse CD8a 53-6.7 IHC-F, FC, 3D IHC
PE/Dazzle™ 594 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 750 anti-mouse CD8a 53-6.7 FC
GoInVivo™ Purified anti-mouse CD8a 53-6.7 FC
TotalSeq™-A0002 anti-mouse CD8a 53-6.7 PG
Spark Blue™ 550 anti-mouse CD8a 53-6.7 FC
Spark NIR™ 685 anti-mouse CD8a 53-6.7 FC
TotalSeq™-C0002 anti-mouse CD8a 53-6.7 PG
TotalSeq™-B0002 anti-mouse CD8a 53-6.7 PG
Spark YG™ 570 anti-mouse CD8a 53-6.7 IHC-F
PE/Fire™ 640 anti-mouse CD8a 53-6.7 FC
PE/Fire™ 700 anti-mouse CD8a 53-6.7 FC
Spark Blue™ 574 anti-mouse CD8a Antibody 53-6.7 FC
Spark Violet™ 423 anti-mouse CD8a Antibody 53-6.7 FC
Spark UV™ 387 anti-mouse CD8a 53-6.7 FC
Go To Top Version: 5    Revision Date: 12.03.2020

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse CD8a

  • Biotin anti-mouse CD8a

  • FITC anti-mouse CD8a

  • PE anti-mouse CD8a

  • PE/Cyanine5 anti-mouse CD8a

  • Purified anti-mouse CD8a

  • PE/Cyanine7 anti-mouse CD8a

  • APC/Cyanine7 anti-mouse CD8a

  • Alexa Fluor® 488 anti-mouse CD8a

  • Alexa Fluor® 647 anti-mouse CD8a

  • Pacific Blue™ anti-mouse CD8a

  • Alexa Fluor® 700 anti-mouse CD8a

  • PerCP/Cyanine5.5 anti-mouse CD8a

  • PerCP anti-mouse CD8a

  • Brilliant Violet 421™ anti-mouse CD8a

  • Brilliant Violet 570™ anti-mouse CD8a

  • Brilliant Violet 650™ anti-mouse CD8a

  • Brilliant Violet 605™ anti-mouse CD8a

  • Ultra-LEAF™ Purified anti-mouse CD8a

  • Brilliant Violet 711™ anti-mouse CD8a

  • Brilliant Violet 785™ anti-mouse CD8a

  • Brilliant Violet 510™ anti-mouse CD8a

  • Purified anti-mouse CD8a (Maxpar® Ready)

  • Alexa Fluor® 594 anti-mouse CD8a

  • PE/Dazzle™ 594 anti-mouse CD8a

  • APC/Fire™ 750 anti-mouse CD8a

  • GoInVivo™ Purified anti-mouse CD8a

  • TotalSeq™-A0002 anti-mouse CD8a

  • Spark Blue™ 550 anti-mouse CD8a

  • Spark NIR™ 685 anti-mouse CD8a

  • TotalSeq™-C0002 anti-mouse CD8a

  • TotalSeq™-B0002 anti-mouse CD8a

  • Spark YG™ 570 anti-mouse CD8a

  • PE/Fire™ 640 anti-mouse CD8a

  • PE/Fire™ 700 anti-mouse CD8a

  • Spark Blue™ 574 anti-mouse CD8a Antibody

  • Spark Violet™ 423 anti-mouse CD8a Antibody

  • Spark UV™ 387 anti-mouse CD8a

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account